Synthesis of nitroimidazole derived oxazolidinones as antibacterial agents

European Journal of Medicinal Chemistry
2010.0

Abstract

A series of N-alkylated derivatives of nitroimidazolyl oxazolidinones 6a-i with various substituent at N-1 position of the nitroimidazole were synthesized and their in-vitro antibacterial activities were evaluated against several Gram-positive and Gram-negative bacteria. The 6a was found to be most potent compound in the series with MIC at 0.097 microg/mL against Bacillus cereus MTCC 430.). Both 6a and 6f did not exhibit any toxicity towards mammalian cell L929.

Knowledge Graph

Similar Paper

Synthesis of nitroimidazole derived oxazolidinones as antibacterial agents
European Journal of Medicinal Chemistry 2010.0
Discovery of a novel nitroimidazolyl–oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluation
European Journal of Medicinal Chemistry 2011.0
Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety
Bioorganic & Medicinal Chemistry Letters 2021.0
Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis, antimicrobial and cytotoxic activity of 2-azetidinone derivatives of pyridyl benzimidazoles
Medicinal Chemistry Research 2014.0
Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis and in vitro antibacterial activities of novel oxazolidinones☆
European Journal of Medicinal Chemistry 2008.0
Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels−Alder reaction
Bioorganic & Medicinal Chemistry 2012.0
Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis, antibacterial activity, and quantitative structure–activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3()-benzofuranone derivatives
Bioorganic & Medicinal Chemistry Letters 2007.0